Healthcare provider profile · identity verified

Jon Tosch, MD

Internal Medicine · TROY, MI · NPI 1881802437

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	799	225
Losartan Potassium	Losartan Potassium	592	155
Amlodipine Besylate	Amlodipine Besylate	505	152
Levothyroxine Sodium	Levothyroxine Sodium	504	123
Lisinopril	Lisinopril	502	139
Simvastatin	Simvastatin	401	110
Omeprazole	Omeprazole	397	121
Metformin Hcl	Metformin Hcl	395	109
Metoprolol Succinate	Metoprolol Succinate	307	89
Hydrochlorothiazide	Hydrochlorothiazide	250	68
Fluticasone Propionate	Fluticasone Propionate	175	79
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	174	174
Metoprolol Tartrate	Metoprolol Tartrate	172	56
Tamsulosin Hcl	Tamsulosin Hcl	169	52
Escitalopram Oxalate	Escitalopram Oxalate	161	41
Eliquis	Apixaban	156	45
Ozempic	Semaglutide	151	33
Pravastatin Sodium	Pravastatin Sodium	149	43
Gabapentin	Gabapentin	148	52
Atenolol	Atenolol	139	39
Allopurinol	Allopurinol	137	39
Duloxetine Hcl	Duloxetine Hcl	129	36
Trazodone Hcl	Trazodone Hcl	117	37
Jardiance	Empagliflozin	114	37
Januvia	Sitagliptin Phosphate	113	25
Sertraline Hcl	Sertraline Hcl	111	30
Furosemide	Furosemide	110	42
Famotidine	Famotidine	107	36
Rosuvastatin Calcium	Rosuvastatin Calcium	107	37
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	106	14
Glipizide Er	Glipizide	105	28
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	99	22
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	89	30
Albuterol Sulfate Hfa	Albuterol Sulfate	84	37
Alendronate Sodium	Alendronate Sodium	80	25
Pantoprazole Sodium	Pantoprazole Sodium	79	27
Carvedilol	Carvedilol	78	22
Meloxicam	Meloxicam	61	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	60	18
Benazepril Hcl	Benazepril Hcl	58	16
Ezetimibe	Ezetimibe	57	18
Chlorthalidone	Chlorthalidone	52	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	52	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	51	14
Potassium Chloride	Potassium Chloride	51	17
Metformin Hcl Er	Metformin Hcl	50	15
Paroxetine Hcl	Paroxetine Hcl	50	13
Warfarin Sodium	Warfarin Sodium	49	14
Citalopram Hbr	Citalopram Hydrobromide	48	13
Alprazolam	Alprazolam	47	25
Methylprednisolone	Methylprednisolone	46	45
Prednisone	Prednisone	46	46
Ibuprofen	Ibuprofen	44	17
Lovastatin	Lovastatin	44	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	41	14
Glimepiride	Glimepiride	39	suppressed
Spironolactone	Spironolactone	39	14
Torsemide	Torsemide	39	14
Xarelto	Rivaroxaban	39	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	38	14
Clopidogrel	Clopidogrel Bisulfate	37	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	37	11
Glipizide	Glipizide	37	14
Ventolin Hfa	Albuterol Sulfate	37	17
Methocarbamol	Methocarbamol	35	16
Mirtazapine	Mirtazapine	35	suppressed
Nifedipine Er	Nifedipine	35	11
Shingrix	Varicella-Zoster Ge/As01b/Pf	35	27
Tramadol Hcl	Tramadol Hcl	34	11
Trulicity	Dulaglutide	34	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	34	15
Levetiracetam	Levetiracetam	33	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	30	suppressed
Finasteride	Finasteride	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Doxepin Hcl	Doxepin Hcl	26	suppressed
Ipratropium Bromide	Ipratropium Bromide	26	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	25	suppressed
Propranolol Hcl Er	Propranolol Hcl	25	suppressed
Tdvax	Tetanus, Diphtheria Tox,adult	25	25
Midodrine Hcl	Midodrine Hcl	24	suppressed
Rybelsus	Semaglutide	24	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Diazepam	Diazepam	22	12
Doxycycline Hyclate	Doxycycline Hyclate	22	13
Folic Acid	Folic Acid	21	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Nitroglycerin	Nitroglycerin	20	suppressed
Baclofen	Baclofen	19	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	19	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	13
Verapamil Er	Verapamil Hcl	18	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Glycopyrrolate	Glycopyrrolate	17	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	14	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Colchicine	Colchicine	13	suppressed
Felodipine Er	Felodipine	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	12	suppressed
Mexiletine Hcl	Mexiletine Hcl	12	suppressed
Naproxen	Naproxen	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Rivastigmine	Rivastigmine Tartrate	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	11	11
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed
Prasugrel Hcl	Prasugrel Hcl	11	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	11	suppressed
Tenivac	Tetanus-Diphtheria Toxoids/Pf	11	11
Terazosin Hcl	Terazosin Hcl	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error